Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases

British Journal of Rheumatology

Volumn 36, Issue 11, 1997, Pages 1144-1150

  Warnock, M G ^a   Goodacre, J A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Autoimmunity; Cryptic; Rheumatic diseases; T cell epitopes

Indexed keywords

AUTOANTIGEN; EPITOPE;

ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

EID: 0031431637     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.11.1144     Document Type: Review

References (41)

1. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994;12:259-93.
2. Brett SJ, Lamb JR, Cox JH, Rothbard JB, Mehlert A, Ivanyi J. Differential pattern of T cell recognition of the 65 kDa mycobacterial antigen following immunization with the whole protein or peptides. Eur J Immunol 1989;19:1303-10.
3. Brett SJ, Cease KB, Berzofsky JA. Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing. J Exp Med 1988;168:357-73.
4. Maizels RM, Clarke JA, Harvey MA, Miller A, Sercarz EE. Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells. Eur J Immunol 1980;10:509-15.
5. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil KD. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-66.
6. Wolpert E, Franksson L, Karre K. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: Analysis and mapping by elution of cellular peptides. Int Immunol 1995;7:919-28.
7. Gao L, Walter J, Travers P, Stauss H et al. Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope. J Immunol 1995;155:5519-26.
8. Bullock TNJ, Eisenlohr LC. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J Exp Med 1996;184:1319-29.
9. Barker RN, Elson CJ. Multiple self-epitopes on the rhesus polypeptides stimulate immunologically ignorant human T cells in vitro. Eur J Immunol 1994;24: 1578-82.
10. Markovic Plese S, Fukaura H, Zhang J, AlSabbagh A, Southwood S, Sette A et al. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol 1995;155:982-92.
11. Matsuo H, Batocchi AP, Hawke S, Nicolle M, Jacobson L, Vincent A et al. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J Immunol 1995;155:3683-92.
12. Quaratino S, Feldmann M, Dayan CM, Acuto O, Londei M. Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic T cell epitope. J Exp Med 1996;183:349-58.
13. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94:184-92.
14. Richardson BC, Yung RL, Johnson KJ, Rowse PE, Lalwani ND. Monocyte apoptosis in patients with active lupus. Arthritis Rheum 1996;39:1432-44.
15. Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalysed oxidation reactions: implication for pathogenesis. J Exp Med 1997;185:71-9.
16. Buttle D, Bramwell H, Hollander AP. Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy? J Clin Pathol Mol Pathol 1995;48: M167-77.
17. Leroux J-Y, Guerassimov A, Cartman A, Delaunay N, Webber C, Rosenberg LC et al. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulphate in vitro and in vivo. J Clin Invest 1996;97:621-32.
18. Brennan FR, Negroiu G, Buzas EI, Fulop C, Hollo K, Mikecz K et al. Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin Exp Immunol 1995;100:104-10.
19. Michaelsson E, Malmstrom V, Reis S, Engstrom A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994;180: 745-90.
20. Goodacre JA, Middleton S, Lynn S, Ross DA, Pearson J. Human cartilage aggrecan CS1 region contains cryptic T cell recognition sites. Immunology 1993;78: 586-91.
21. Redmond TM, Sanui H, Hu L-H, Wiggert B, Margalit JA, Berzofsky JA et al. Immune responses to peptides derived from the retinal protein IRBP: immunopathogenic determinants are not necessarily immunodominant. Clin Immunol Immunopathol 1989;53:212-24.
22. Hu L-H, Redmond TM, Sanui H, Kuwabara T, McAllister CG, Wiggert B et al. Rat T cell lines specific to a nonimmunodominant determinant of a retinal protein (IRBP) produce uveoretinitis and pinealitis. Cell Immunol 1989;122:251-61.
23. Lipham WJ, Redmond TM, Takahashi H, Berzofsky JA, Wiggert B, Chader G et al. Recognition of peptides that are immunopathogenic but cryptic. J Immunol 1991;146:3757-62.
24. Balasa B, Carayanniotis G. Induction of experimental autoimmune thyroiditis in rats with the synthetic peptide (2495-2511) of thyroglobulin. Cell Immunol 1993; 148:259-68.
25. Bockenstedt LK, Gee RJ, Mamula M. Self peptides in the initiation of lupus autoimmunity. J Immunol 1995;154:3516-24.
26. Tuohy VK, Thomas DM. Sequence of 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J Neuroimmunol 1995;56:161-70.
27. Mor F, Cohen IR. Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. J Immunol 1995;155:3693-9.
28. Inomata T, Hanawa H, Miyanishi T, Yajima E, Nakayama S, Maita T et al. Localisation of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circul Res 1995;76:726-33.
29. Griem P, Panthel K, Kalbacher H, Gleichmann E. Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides. Eur J Immunol 1996;26:279-87.
30. Mougdil KD, Sercarz EE. Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self homologue, mouse lysozyme: Implications in shaping of the T cell repertoire and autoimmunity. J Exp Med 1993;178:2131-8.
31. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-7.
32. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 1993;14:203-8.
33. Fairchild PJ, Wildgoose R, Atherton E, Webb S, Wraith DC. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol 1993;5:1151-8.
34. Fairchild PJ, Pope H, Wraith DC. The nature of cryptic epitopes within the self antigen myelin basic protein. Int Immunol 1996;8:1035-43.
35. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995;181:1945-8.
36. Burkhardt H, Yan T, Broker B, Beck-Sickinger A, Holmdahl R, Von der Mark K et al. Antibody binding to a collagen type II epitope gives rise to an inhibitory peptide for autoreactive T cells. Eur J Immunol 1992;22:1063-7.
37. Roughley PJ, White RJ. Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J Biol Chem 1980;255:217-24.
38. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
39. Buzas EI, Mikecz K, Brennan FR, Glant TT. Mediators and autopathogenic effector cells in proteoglycan-induced arthritic and clinically asymptomatic BALB/c mice. Cell Immunol 1994;158:292-304.
40. Adorini L, Guery J-C, Rodriguez-Traduchy G, Tremblau S. Selective immunosuppression. Immunol Today 1993;14:285-9.
41. Fairchild PJ, Thorpe CJ, Travers PJ, Wraith DC. Modulation of the immune response with T cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology 1994;81:487-96.